Gov. Rick Perry, Governor Jared Polis, Maya Padilla
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
NIMH Director Joshua A. Gordon and trauma researcher Barbara O. Rothbaum discuss the current state and future directions of psychedelic research, emphasizing the need for deeper understanding and robust study
Joshua A Gordon
Drs. Summergrad and Insel reflect on the progress and remaining questions in psychedelic science since 2017. They delve into topics like efficacy, regulation, therapy, and provider experience.
Paul Summergrad, Tom Insel, Rachel Nuwer
Carl Hart, Chair of Psychology at Columbia University, is a renowned neuropsychopharmacologist, author, and media personality known for challenging drug perceptions through research, books, and media appearances.
Carl Hart
Elliot Cohen (Pillpack, Amazon) and Protik Basu (World Bank, UN, Helena) share insights on healthcare delivery, psychedelics industry, scaling challenges, and technology's role in patient care.
Andrew “Mo” Septimus, Protik Basu, Elliot Cohen
Funding for psychedelic medicine is evolving, with a rise in commercial capital alongside philanthropic support. Balancing financial interests with equitable access and learning from scaling challenges are key considerations.
Henry Elkus
Dr. Smith and Dr. Jones explore the latest advancements in artificial intelligence and its impact on society during their TEDx talk at Stanford University.
Jamie Wheal
Discussion between experts on pragmatic frameworks, demographic considerations, and evidence-based practices shaping psychedelic policy reform for diverse contexts, addressing regulatory challenges and fostering nuanced understanding.
Tatiana Quintana, Melissa Lavasani, Logan Davidson
Rick Doblin discusses growing up with the "queen of psychedelics", Rock and Cosmo's paths to this work, challenges of working with family, and their shared vision for the psychedelic renaissance.
Amanda Feilding, Rock Feilding-Mellen, Cosmo Fielding Mellen
Hardman provides a quick overview of the emerging psychedelic sector, covering financial, research, and policy landscapes with data visuals. He also explores unanswered questions about the sector's future.
Josh Hardman
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.